[
    [
        {
            "time": "2018-08-27",
            "original_text": "复星医药公布半年报，重组人胰岛素产业化项目可用状态日期延至2020年12月，上半年净利润下滑8%，研发费用增长超五成，盈利能力下降。",
            "features": {
                "keywords": [
                    "复星医药",
                    "半年报",
                    "重组人胰岛素",
                    "研发费用",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药公布半年报，重组人胰岛素产业化项目可用状态日期延至2020年12月，上半年净利润下滑8%，研发费用增长超五成，盈利能力下降。",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-27",
            "original_text": "A股放量大涨：沪指三连阳收复20日线，创业板指暴涨近3%。",
            "features": {
                "keywords": [
                    "A股",
                    "放量大涨",
                    "沪指",
                    "创业板指"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股放量大涨：沪指三连阳收复20日线，创业板指暴涨近3%。",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-27",
            "original_text": "港股异动︱复星医药(A股涨停 H股跟涨8.93%)。",
            "features": {
                "keywords": [
                    "复星医药",
                    "A股涨停",
                    "H股跟涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动︱复星医药(A股涨停 H股跟涨8.93%)。",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-27",
            "original_text": "医药板块崛起，复星医药、华兰生物等多股涨停。",
            "features": {
                "keywords": [
                    "医药板块",
                    "复星医药",
                    "涨停"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药板块崛起，复星医药、华兰生物等多股涨停。",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-28",
            "original_text": "江琦、赵磊：2018H1点评：研发投入大幅增加影响表观利润，创新趋势继续。",
            "features": {
                "keywords": [
                    "复星医药",
                    "研发投入",
                    "表观利润",
                    "创新趋势"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "江琦、赵磊：2018H1点评：研发投入大幅增加影响表观利润，创新趋势继续。",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]